Company intelligence / Profile preview

TrackPaw Scientific

Ownership: Private
Development stage: Preclinical

Overview

TrackPaw Scientific has developed an AI-based plug-and-play solution that enables 24/7 remote digital monitoring of rodents in preclinical studies. The system captures and analyzes weight, activity, and behavioral changes to improve data quality, reduce manual intervention, enhance animal welfare in line with the 3Rs principle, and accelerate drug development timelines. The product is currently in beta trials with paying customers and aims for commercial launch by 2026

Modalities: DeviceSoftware-as-a-Service (SaaS)
Industry: Drug Discovery Services

Beyond the preview

Go deeper on TrackPaw Scientific.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TrackPaw Scientific.

Explore the full profile